Daily Stock List
Creative Learning Corp. (CLCN)
Today we are highlighting Creative Learning Corp. (CLCN), here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Creative Learning Corp. operates under the trade name Bricks 4 Kidz®. The Company offers programs designed to teach children ages 3-13-plus the basic principles of engineering, architecture and physics using LEGO® bricks. Creative Learning operates through one corporate creativity center in Florida; and multiple franchises in a host of states and worldwide. Creative Learning was founded in 2009 and is based in St. Augustine, Florida.
The Company has a unique franchise business model that includes a proprietary Franchise Marketing Tool (FMT). Creative Learning provides a broad spectrum of programs designed to enhance students’ problem solving and critical thinking skills by designing numerous structures, devices, and systems using proprietary LEGO® bricks and models.
Currently, Creative Learning has 160-plus franchises. The Company is expanding their international reach, fulfilling an educational need in many communities that are lacking these types of programs. Bricks 4 Kidz programs are built around the Company’s proprietary model plans, designed by engineers and architects, with themes including space, construction, and amusement parks. The Company’s specially designed project kits and theme-based models provide the building blocks for the Bricks 4 Kidz approach to educational play.
Bricks 4 Kidz offers various activities for children. These include after-school enrichment classes; week-long summer camps; birthday parties; preschool classes, and Kidz Night Out.
In July, Creative Learning, owner and developer of Bricks 4 Kidz®, announced that the Company recently closed on a Master License for Colombia. On July 10, 2012, Mr. Brian Pappas, CEO of Creative Learning, commented, “The closing of the Colombia Master License clearly indicates a significant demand internationally for the Bricks 4 Kidz® program, considering that we’re now operating in six countries and in Puerto Rico. We’re very excited with the operator in Colombia and look forward to a long and mutually rewarding relationship. We also expect to close this month another International franchise in Poland.”
Creative Learning Corp. (CLCN), closed on Wednesday at $2.00, down 7.83%, on 22,120 volume with 27 trades. The average volume for the last 60 days is 1,490. The 52-week low/high is $1.90/$32.00.
Patriot Scientific Corp. (PTSC)
PennyTrader Publisher, Greenbackers, Lebed.biz, and SmallCapVoice reported earlier on Patriot Scientific Corp. (PTSC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Patriot Scientific Corp. is the co-owner of an intellectual property (IP) portfolio that covers fundamental aspects of microprocessor design and which is licensed to an array of manufacturers and marketers of electronic products. The Company is the co-owner of the Moore Microprocessor Patent™ Portfolio. Founded in 1987, Patriot Scientific is based in Carlsbad, California. The Company’s shares trade on the OTC Bulletin Board.
Chips with Patriot Scientific's patented technology are used throughout the world in products ranging from computers and cameras to printers, automotive and industrial devices. The Company’s current cash generation is mainly licensing revenues from their Moore Microprocessor Patent™ Portfolio. It contains intellectual property that is jointly owned with privately held The TPL Group.
The MMP™ Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. The MMP Portfolio patents cover techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from Personal Computers (PCs), cell phones and portable music players to communications infrastructure, medical equipment and automobiles. Currently, Patriot Scientific holds a 50 percent joint ownership in Phoenix Digital Solutions, LLC. They are the entity that records the license revenues for the MMP Portfolio.
The MMP™ Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Patriot Scientific and TPL believe that at least three of the patents are elemental to virtually every microprocessor design. The three most significant of these patents are U.S. 5,809,336: Clocking CPU and I/O Separately; U.S. 6,598,148: Use of Multiple Cores and Embedded Memory, and U.S. 5,784,584: Multiple Instruction Fetch. These patents were granted in 1998 and they are valid through 2015.
Recently, Patriot Scientific announced that Pentair, Inc. purchased an MMP™ Portfolio license. Pentair is a diversified industrial company. They provide innovative, sustainable solutions to customers around the world.
Patriot Scientific Corp. (PTSC), closed on Wednesday at $0.06, down 21.59%, on 1,428,880 volume with 216 trades. The average volume for the last 60 days is 113,755. The 52-week low/high is $0.01/$0.46.
Norsat International, Inc. (NSATF)
MicroCap Gems reported earlier on Norsat International, Inc. (NSATF) and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Norsat International, Inc. is a leading provider of innovative communication solutions that enable the transmission of data, audio and video for challenging applications and environments. Furthermore, through their Norsat Power Solutions segment, the Company is a provider of power conversion and energy storage solutions for the communications, transportation and resource sectors. Founded in 1977, Norsat International is based in Richmond, British Columbia; the Company’s shares trade on the OTCBB.
Norsat International’s products and services include leading-edge product design and development, production, distribution and infield support and service of portable ground station satellite terminals, antennas, Radio Frequency (RF) conditioning products, microwave components, maritime based satellite terminals and remote network connectivity solutions.
The Company serves global customers primarily through three business units. These are Sinclair Technologies, Satellite Solutions and Microwave Products.
Today, Norsat International reported financial results for the three and six months ended June 30, 2012. Highlights for the Company include second quarter revenue, gross profit dollars, EBITDA and net earnings all being up over the same period in 2011. In addition, Norsat was granted Final Acceptance with NATO Communications and Information Agency (NATO) for their custom-designed dual Ku-band and X-band portable satellite terminals.
Moreover, the Company released a Satellite Locator application for iPhone on the App Store. The application is available as a free download. It enables users to locate geostationary satellites on a mobile phone from anywhere in the world. It can be used to assess obstructions and assist in pointing satellite ground terminals, including Norsat’s ultra-portable GLOBETrekker™ and Rover™ systems.
Additionally, further highlights include Norsat’s innovative video streaming technologies and Ku-band portable satellite terminals being used to broadcast live footage of U.S. President Obama’s surprise visit and address to U.S. service members in Bagram, Afghanistan on May 1, 2012.
Norsat International is continuing to focus on implementing a business model that will serve to add a recurring revenue stream by offering a range of services, broaden the portfolio of products and services, actively recruit and cultivate reseller channel partners, and diversify the Company’s base of customers to include non-defense customers.
Norsat International, Inc. (NSATF), closed on Wednesday at $1.60, up 6.67%, on 69,593 volume with 27 trades. The average volume for the last 60 days is 6,350. The 52-week low/high is $1.10/$4.00.
Wave Systems Corp. (WAVX)
Profit Confidential, FeedBlitz, StreetInsider, and SmarTrend Newsletters reported earlier on Wave Systems Corp. (WAVX), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 1988, Wave Systems Corp. develops, produces and markets products for hardware-based digital security. The basis of the Company’s products is on the Trusted Platform Module (TPM). This is a hardware security chip that enables secure protection of files and other digital secrets, and performs critical security functions. The Company reduces the complexity, cost and uncertainty of data protection by starting inside the device. Wave Systems has their headquarters in Lee, Massachusetts.
The Company completed the acquisition of leading endpoint data loss protection solution provider Safend Ltd. in 2011. With this acquisition, Wave’s employee count rose to 250. Their employees are located in Lee, Massachusetts; Cupertino, California; Princeton, New Jersey; London, UK; Frankfurt, Germany, and Nantes, France. The Company has a support center in Dietikon, Switzerland. Wave's Safend subsidiary is based in Tel Aviv, Israel. Their sales force is dispersed throughout the United States and Europe.
Wave is a leading provider of client and server software for hardware-based digital security, enabling organizations to know who is connecting to their critical IT infrastructure. This also enables organizations to protect corporate data and strengthen the boundaries of their networks. The Company leverages the security capabilities built directly into endpoint computing platforms themselves. Wave helps shape standards by way of their work as a Board member for the Trusted Computing Group.
The trusted Platform Module (TPM) is the industry-standard hardware security chip that is included as standard equipment on most enterprise-class PCs shipping today. A TPM is a highly secure cryptographic support system. TPM generates, stores and processes keys, which can be used to encrypt information and harden identities.
Wave's flagship software offering is EMBASSY® Trust Suite. Wave's eSign Systems division provides software enabling organizations to create, sign, store, access and manage the lifecycle of legally binding electronic records.
Today, Wave Systems announced that they are selling to investors 2,587,824 shares of their Class A common stock at a price of $0.6425 per share, yielding gross proceeds of approximately $1,662,677. Investors in the offering will also receive three-year warrants to purchase an aggregate of 1,293,912 shares of Wave's Class A common stock for $0.58 per share. The net proceeds of the financing will be used to fund Wave Systems’ ongoing operations. Security Research Associates acted as placement agent in connection with the offering.
Wave Systems Corp. (WAVX), closed on Wednesday at $0.30, down 0.33%, on 67,910 volume with 22 trades. The average volume for the last 60 days is 13,386. The 52-week low/high is $0.21/$1.00.
Aethlon Medical, Inc. (AEMD)
MicroCap Gems reported last week on Aethlon Medical, Inc. (AEMD), OTCPicks, Investor Ideas did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Aethlon Medical, Inc.’s mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Exosome Sciences, Inc. is a wholly owned subsidiary of Aethlon Medical. Exosome Sciences creates diagnostic tools to detect and quantify the presence of exosomes in blood and other fluids. Aethlon Medical has their corporate headquarters in San Diego, California.
The Company’s Aethlon ADAPT™ System is a revenue-stage technology platform. It provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with DARPA that would reduce the incidence of sepsis in combat-injured soldiers and civilians.
Aethlon Medical’s Exosome Sciences subsidiary has a lead product called the Enzyme Linked Lectin Specific Assay (ELLSA). It has been validated to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal.
Today, Aethlon Medical announced that the Company has agreed to establish a treatment program that will provide HCV-infected individuals with expanded access to Hemopurifier® therapy. The program is being initiated with support from the Institutional Review Board at the Medanta Medicity Institute (Medicity) to allow compassionate usage of the Aethlon Hemopurifier® for individuals who previously failed or subsequently relapsed standard-of-care drug regimens.
The Aethlon Hemopurifier® is a first-in-class medical device. It selectively targets the rapid clearance of HCV from the entire circulatory system to improve benefit, dose, duration and tolerability of drug therapies. In addition, Aethlon Medical disclosed that they will continue conducting a study at the Medicity that is evaluating the capability of the Aethlon Hemopurifier® to accelerate HCV RNA depletion at the outset of standard of care peginterferon+ribavirin (PR) therapy. The Medicity is a $360 million multi-specialty medical institute established to be a premier center for medical tourism in India.
Aethlon Medical, Inc. (AEMD), closed on Wednesday at $0.50, up 6.385, on 27,138,409 volume with 27,472 trades. The average volume for the last 60 days is 4,252,513. The 52-week low/high is $0.44/$5.13.
CBM Asia Development Corp. (TCF.V)
Today we are highlighting CBM Asia Development Corp. (TCF.V), here at the QualityStocks Daily Newsletter.
CBM Asia Development Corp. is an unconventional gas company with significant coalbed methane (CBM) exploration and development opportunities in Indonesia. The Company holds various participating interests in four production sharing contracts (each a PSC) for CBM in Indonesia. CBM Asia’s investment strategy is to acquire high-quality acreage, de-risk it to approximately 80 percent certitude through low-cost core holes and production pilots, achieve early-stage commercial production and cash flow, and subsequently sell the asset to a Major seeking to capture a de-risked property with large development potential. CBM Asia Development’s shares trade on the TSX Venture Exchange. The Company is based in Vancouver, British Columbia.
Indonesia has one of the largest CBM resources in the world with a potential 453 trillion cubic feet in-place, more than double the country's natural gas reserves (Stevens and Hadiyanto, 2004). Since 2008, a total of 39 CBM PSCs have been granted by the Government of Indonesia, representing exploration commitments of more than US$100 million during the next 3 years.
In addition to CBM Asia, other companies active in CBM exploration in Indonesia include BP, Dart Energy, ENI, ExxonMobil, Medco, Santos, and TOTAL. BP, ENI, and the Indonesian government confirmed that commercial CBM production began in March of 2011 from the Sanga-Sanga PSC and is being exported from the Bontang LNG facility.
CBM Asia’s latest acquisitions, Hulu PSC and Besar PSC provide operatorship and 70 percent working interest for all-in costs of $4.14/acre. This is significantly less than North America costs of hundreds to thousands of dollars per acre.
On Tuesday of this week, CBM Asia reported that high final gas content values with excellent gas quality were measured at the Kutai West Coalbed Methane Production Sharing Contract (Kutai West CBM PSC), located in East Kalimantan, Indonesia. Newton Energy Capital Ltd. operates the Kutai West CBM PSC; CBM Asia holds an 18 percent working interest.
Contractor PT GeoServices measured the gas content of 17 coal samples that were cored from the CBM-KW-01 exploration well. The final gas content ranged from 155 to 359 ft3/ton (average 275 ft3/ton), reported on an industry-standard "dry, ash-free" basis. The concentration of methane and other hydrocarbon gases averaged more than 97 percent with low CO2.
CBM Asia Development Corp. (TCF.V), closed on Wednesday at $0.04, up 33.33%, on 137,500 volume. The 52-week low/high is $0.03/$0.13.
St. Andrew Goldfields Ltd. (SAS.TO)
We are highlighting St. Andrew Goldfields Ltd. (SAS.TO), here at the QualityStocks Daily Newsletter.
St. Andrew Goldfields Ltd. (SAS) (operating as SAS Goldmines), is a gold mining and exploration company. SAS has an extensive land package in the Timmins mining district, in northeastern Ontario, which lies within the Abitibi greenstone belt. Currently, SAS operates the Holt, Holloway and Hislop Mines, and is targeting annual gold production of 90,000-100,000 ounces of gold for 2012. SAS lists on the Toronto Stock Exchange and on the OTCQX with the symbol STADF. The Company has their corporate headquarters in Toronto, Ontario.
Additionally, SAS is advancing the Taylor Project and is conducting an aggressive exploration program across 120km of land straddling the Porcupine-Destor Fault Zone. The Company targeted exploration at a number of sites and has focused the 2012 exploration program on areas that lie in close proximity to the existing mines and infrastructure. SAS is also focusing on following up on advanced exploration projects to add to the resource and reserve levels. In 2011, they increased their resource levels by 34 percent, and advanced the Taylor Project through the pre-feasibility stage.
Recently, the Company announced an update on their exploration programs on the Ghost Zone (Ghost) located near the Holt Mine, and the Hislop North Project (Hislop North), located northwest of the Hislop Mine. Hislop North returned 8.56 g/t Au over 24.4m, including 11.29 g/t Au over 12.0m and 9.72 g/t Au over 10.0m; Ghost returned 7.85 g/t Au over 11.2m.
Yesterday, St Andrew Goldfields (SAS) provided an update on the activities at the Taylor Project located on the western portion of the Company's land package in the Timmins mining district. Dewatering of the existing ramp access began in late April 2012 and as of the end of June, the portal was open. SAS has awarded the contract to rehabilitate the underground workings for mine exploration and development. The contractor mobilized in late June in preparation for ramp rehabilitation and underground development.
Upon completion of rehabilitation and when services are re-established to the ramp face, lateral development will begin to access the first ore lens in the West Porphry Zone. Test mining of this area will start in the fourth quarter, and a bulk sample will be sent to SAS’s Holt Mill for processing towards the end of this year.
St. Andrew Goldfields Ltd. (SAS.TO), closed on Wednesday at $0.46, up 3.41%, on 17,000 volume with 4 trades. The average volume for the last 60 days is 21,304. The 52-week low/high is $0.39/$1.17.
Writers' Group Film Corp. (WRIT)
SmallCapVoice and Pumps and Dumps reported earlier on Writers' Group Film Corp. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Writers’ Group Film Corp. is a content creation company that lists on the OTC Markets. The Company focuses on the production, acquisition, and distribution of live concerts in three dimensional formats (3D) for digital broadcast into digitally-enabled movie theaters in the U.S. and worldwide. Front Row Networks, Inc. is a wholly-owned subsidiary of the Company. Writers' Group Film has their headquarters in Beverly Hills, California.
The intention of the Company’s new concept is to present live concerts in 3D, at lower ticket prices, to a massive fan base around the world in a cost-effective manner. Their intention is to license their products in 2D and 3D format to DVD and Blu-Ray retailers, TV broadcasters, cable and 3D cable channels, and mobile streaming providers. In addition, Company Management intends to sell merchandising and sponsorship, specific to each artist in the concert, in theaters. They will sell merchandise, such as clothing, household goods, and other products in movie theaters, where the live concert is exhibited.
The Front Row Networks subsidiary will take advantage of their distribution networks and their licensing and merchandising relationships by acquiring 2D and 3D concert footage that has already been produced. They will convert their 2D catalogue into a digital 3D format. This will allow them to package and sell all of their acquired content to digital broadcasters globally.
Today, Writers' Group Film subsidiary, Front Row Networks, announced that their CEO, Mr. John Diaz, recently conducted a webinar to discuss business developments, upcoming projects, and other company business. Mr. Diaz discussed the status of the Company and development projects. This included the soon to be announced 3D theatrical concert series. The basis of the series will be on the converted 2D catalogue. It will include some of the biggest names in rock history. Front Row management is finalizing the terms of distribution for these projects and they expect to make an announcement in the near future.
Writers' Group Film Corp. (WRIT), closed on Wednesday at $0.09, up 15.63%, on 115,600 volume with 14 trades. The average volume for the last 60 days is 43,532. The 52-week low/high is $0.05/$0.36.
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.79, up 2.29%, on 6,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 3,412, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Announces New Channel Sales Partnership With RJ Young
GlobalWise Accepted as Member of Prestigious Organization Technology United
GlobalWise CEO to Be Featured Speaker at World Expo 2012 Conference
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.27, up 3.85%, on 65,191 volume with 21 trades. The stock’s average daily volume over the past 60 days is 202,994, and its 52-week low/high is $0.21/$1.01.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Host Second Quarter 2012 Financial Results Conference Call August 10
International Stem Cell Corporation's Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders
International Stem Cell Corporation Featured in Stem Cell Technology's Bright Future Article on Seeking Alpha
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.54, off by 3.75%, on 11,724 volume with 10 trades. The stock’s average daily volume over the past 60 days is 7,448, and its 52-week low/high is $1.10/$4.00.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Acquires Interest in 5.3 Million-Acre African Concession
Duma Energy Enters Final Stage of Negotiations for African Concession
Duma Energy Provides Third Quarter Results and Demonstrates Positive Earnings
Skinny Nutritional Corp. (SKNY)
The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.0055, down 6.78%, on 1,920,346 volume with 19 trades. The stock’s average daily volume over the past 60 days is 2,796,773, and its 52-week low/high is $0.005/$0.051.
Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.
The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.
The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.
Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer
Skinny Nutritional Corp. Blog
Skinny Nutritional Corp. News:
A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration
Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally
Skinny Nutritional Corp. Enters Distribution Agreement With Michigan-Based D&B Grocers Wholesale, Inc.
California based biotechnology company International Stem Cell Corporation announced financial results for the three and six month periods ended June 30, 2012.
• Revenue for the quarter (Q2) ended June 30, 2012, totaled $1.06 million, compared to $1.11 million for the same period in 2011. The decrease came largely from lower sales from Lifeline Cell Technology (LCT).
• Revenue for the 6-month period ended June 30, 2012, was $2.13 million, compared to $2.63 million for the same period in 2011. The decrease came largely from lower sales from Lifeline Skin Care (LSC).
• R&D expenses for the quarter were $0.87 million, a 23% decrease compared to the same period in 2011. The reduction in expenses was due primarily to lower consulting expenses associated with various research projects, along with lower stock-based compensation expenses, lower laboratory expenses, and lower personnel related expenses, although stem cell line research expenses did increase.
• ISCO continues to invest in sales and marketing initiatives. Marketing expenses for the quarter were $0.55 million, an increase of 58% over the same period in 2011. For the 6-month period ended June 30, 2012, marketing expenses were $1.04 million, a 57% increase over the same period in 2011.
• General and administrative expenses for the quarter were $1.76 million, down 18% from the same period in 2011, due largely to ongoing increases in operational efficiency. For the 6-month period ended June 30, 2012, general and administrative expenses were $3.79 million, a 13% decrease from the same period in 2011.
• Cash and cash equivalents totaled $4.29 million on June 30, 2012, compared to $1.34 million as of December 31, 2011, due primarily to two financing transactions totaling approximately $6.9 million.
ISCO’s CEO and Co-Chairman, Andrey Semechkin, commented on the results: “We have made solid progress across our entire organization in the first half of this year, and I’m pleased to see that the operational efficiencies we implemented in the second quarter are resulting in lower administrative expenses. Going forward we will continue to look for further opportunities to improve our organization effectiveness and reduce expenses. As you may have read in my shareholder letter, following a detailed analysis of our research priorities, we concentrated our resources on the most promising therapeutic programs and this has already resulted in exciting achievements and progressed our programs closer to clinical development.”
• The company developed a new method to derive high-purity populations of neural stem cells from human parthenogenetic stem cells (hpSC) and further differentiate them into dopaminergic neurons. This method is highly efficient and capable of generating sufficient quantities of neuronal cells for our pre-clinical and clinical studies.
• In the Parkinson’s disease program, the company was able to demonstrate in rodent models that developed neurons from ISCO can survive after implantation and can release dopamine.
• In the metabolic diseases program, the company has shown that their immature hepatocyte-like cells derived from their hpSC can successfully engraft and mature in rodents and produce liver specific proteins.
• In the corneal blindness program, the company developed differentiation technology to create endothelium-like cells, a significant step towards creating complete corneas that could be used in transplantation.
A conference call and webcast is scheduled for Friday, August 10, at 11:00 AM Eastern Time.
Conference Participation Information:
Domestic: 1 877 317-6776
International: 1 412 317-6776
Conference ID: 10017300
Webcast link: http://webcast.mzvaluemonitor.com/Home/Login/7fd6c4da-37f0-472c-9f28-cd9eb1b99f87
Replay of the conference call will be available for two weeks following 1 hour after the end of the conference call through end date: Aug 24, 2012 at 9:00 am ET .
Teleconference Replay Details:
US Domestic: 1-877-344-7529
Conference ID: 10017300
For additional information, visit the company’s website at www.InternationalStemCell.com
Duma will acquire full ownership of Namibia Exploration and its 5.3-million acre petroleum concession in Africa.
Duma Energy Corp., a producer of oil and gas in the continental United States, both on and offshore, today announced that it will acquire a 100-percent stake in Namibia Exploration Inc. (NEI), which holds the rights to a 39-percent working interest in an onshore Namibian petroleum concession spanning about 5.3 million acres.
Per the acquisition, Duma will hold its indirect working interest in the concession in partnership with the National Petroleum Corporation of Namibia Ltd. (NPC Namibia) and Hydrocarb Namibia Energy Corp., a company chartered in the Republic of Namibia and a majority owned subsidiary of Hydrocarb Corp. As the operator of the concession, Hydrocarb Namibia will hold a 51-percent working interest in the concession; NPC Namibia will hold a 10 percent carried working interest in concession.
Jeremy G. Driver, chairman and CEO of Duma, in the press release said that the concession has high exploration potential and called preliminary data “encouraging.” Additionally, he said the acquisition fits Duma’s strategy of generating domestic cash flow to fund” high impact” international ventures.
Pasquale Scaturro, Hydrocarb’s president and COO detailed the potential of the concession as follows:
“The Owambo Basin concession … has all of the key ingredients for becoming a major oil province, including good reservoir and source rocks that extend into southern Angola, one of the top oil producers in Africa. The commercial terms of our Petroleum Contract are highly favorable and since our concessions are onshore, operating and exploration costs are a fraction of those offshore,” he concluded.
Financial details were not disclosed.
For more information visit www.duma.com
The rapid growth of Skinny Nutritional speaks to the wisdom of successfully addressing a previously unmet market need. Unlike the commonplace carb- or caffeine-loaded sports and energy drinks, or the so-called health drinks that simply reduce the sugar and sodium, Skinny knew there was a market out there that wanted something different. Millions of working women and men were looking for flavor and fun without the guilt, something they could enjoy while being good to their bodies and their waistlines. They were looking for exactly what Skinny set out to create. From its very first days, Skinny Nutritional knew the market it was after, knew that it was big, and was determined to meet it.
• 2006 – Creative Enterprises Int. changed name to Skinny Nutritional Corp.
• 2008 – Company launched first zero-calorie enhanced water
• 2010 – Skinny popularity took off with 1 million cases being sold
• 2012 – Skinny launches proprietary bottle, pH+ water and natural flavors
Today, Skinny has expanded to a host of popular varieties, all using 100% natural flavorings, with zero artificial colors or preservatives, and all with zero sugar, zero carbs, zero calories, and zero sodium, and new concepts continue to be created under the Skinny brand. It’s all aimed at that huge and still largely underserved market of health and weight-conscious people who take the time to carefully review the ingredient list. These people aren’t fooled by fancy words and logos, and once they’ve found a brand name they can trust, they will stick with it. That’s the brand that Skinny is building.
For additional information, visit the company’s websites at www.SkinnyWater.com
Crosshair Energy, well-known for their work developing uranium/vanadium throughout North America via the company’s three divisions (each focused on a distinct resource area in the U.S. and Canada), was excited to report today that a new mineralized zone has been discovered during the 2012 drilling program at one of the USA division’s sites in Wyoming. This, the 4,170-acre Juniper Ridge project (NI 43-101 Indicated Resource base estimate of 5.2M lbs uranium), is just a stretch southwest over in neighboring Carbon county from the company’s other flagship domestic project, the Bootheel/Buck Point properties in Albany county.
Great news for the company’s uranium activity in the mining-friendly state of Wyoming, as this new zone on the northwest edge of the Juniper Ridge East resource area offers promising expansion potential. With initial data showing as much as a 3.65% grade (eU3O8xft) in a nice, 50.9-foot thick slice (as thick as 57.7 feet in one hole), lying just 50-150 feet below surface. The data looks good in context with earlier drilling by the company at Juniper Ridge and, with the clear northwesterly trend open along the strike, it will become the primary subject for follow-up drilling.
VP and Chief Geologist for CXZ, Tom Bell PhD, P.G., pointed directly to the new uranium mineralization trend, which beelines straight over to the company’s Juniper Ridge West site across 4,500 feet of untested land, reminding investors that infill and delineation drilling has here validated the resource model developed from previous and historical drilling. The trend and mineralization zone data is clear, so CXZ has initiated a radiometric soil survey to help map out drill targets in the trend as the company advances towards further exploration.
Delineation and infill drilling has sharpened the resolution of the overall resource model considerably, with highlights of the 2012 drilling program results roundly confirming identified areas and allowing CXZ greater concentration of future efforts. Thus the combined gamma/radon soil survey planned as a component of the drill program will be able to offer more accurate feed data for the identification of new mineralized zones, resulting in optimal CAPEX consumption with a solid back-end quantification of low mineral probability acreage better suited to tasks like storage of tailings and removed topsoil, or for construction of the 40-acre leach pad.
The awesome results from Juniper have produced a decision by CXZ to curtail 2012 exploration at Bootheel somewhat in favor of Juniper and the exceptional grades determined by traditional downhole radiometric wireline logging (done by GAA Wireline), as well as PFN logging for greater fidelity, have bolstered confidence at Crosshair ahead of the Juniper push. PFN (prompt fission neutron, which looks at the resource itself via a pulsed neutron source that triggers and records low level fission of the actual resource) is an alternative to the uranium spectrographic analysis also used in the drill program and yielding comparable results.
The extensive historical work done at Juniper is another great reason for Crosshair’s enthusiasm (6.97M lbs and 9.9M lbs previously estimated prior to NI 43-101), which – while not taken as current – does offer a firm echo to the empirical data generated from extant drilling by the company in 2012 and prior, especially because of the quality of the work that was done. President and CEO of CXZ, Mark Ludwig, P.E., Qualified Person for the report, has checked the report’s summary against original radiometric logs, confirming that today’s release is accurate.
For more information on the growing success story that is Crosshair Energy Corp., head on over to the company’s website at: www.CrosshairEnergy.com
Today's Top 3
The QualityStocks Public Company Sponsor News